Allogene Therapeutics closes $200.4 million stock offering Apr 16, 2026 04:01PM
Allogene Therapeutics Announces Closing of $200.4 Million Public Offering of Common Stock Apr 16, 2026 04:01PM
Allogene prices $175 million stock offering at $2 per share Apr 14, 2026 09:50PM
Allogene Therapeutics Announces Pricing of Public Offering of Common Stock Apr 14, 2026 09:50PM
Allogene Therapeutics Announces Participation in Upcoming Investor Conferences Aug 8, 2024 08:30AM


Apr 9, 2024 08:30AM Allogene Therapeutics Announces Q2 Investor Conference Participation
Apr 13, 2023 08:30AM Allogene Therapeutics Announces Participation in Four Upcoming Investor Conferences
Apr 13, 2023 08:30AM Allogene Therapeutics Announces Participation in Four Upcoming Investor Conferences
Aug 3, 2022 08:30AM Allogene Therapeutics Announces Participation in Three Upcoming Investor Conferences
Aug 3, 2022 08:30AM Allogene Therapeutics Announces Participation in Three Upcoming Investor Conferences
Apr 12, 2022 08:30AM Allogene Therapeutics Announces Participation in Seven Upcoming Investor Conferences
Apr 12, 2022 08:30AM Allogene Therapeutics Announces Participation in Seven Upcoming Investor Conferences
Jul 12, 2021 08:30AM Allogene Therapeutics Announces Participation in Two Upcoming Virtual Investor Conferences
Jul 12, 2021 08:30AM Allogene Therapeutics Announces Participation in Two Upcoming Virtual Investor Conferences
Jun 2, 2020 05:50AM Allogene Therapeutics (ALLO) Prices 11.7M Share Common Offering at $47/Sh
Jun 1, 2020 09:05PM Allogene Therapeutics Announces Pricing of Public Offering of Common Stock
Jun 1, 2020 09:05PM Allogene Therapeutics Announces Pricing of Public Offering of Common Stock
Apr 1, 2020 08:30AM Allogene Therapeutics Announces Participation in Two Upcoming Virtual Investor Conferences
Apr 1, 2020 08:30AM Allogene Therapeutics Announces Participation in Two Upcoming Virtual Investor Conferences
Nov 4, 2019 05:11AM Canaccord Genuity Starts Allogene (ALLO) at Buy